NCT02090881 Measurement of Cerebral Blood Flow Using Transcranial Doppler Ultrasound in Children With Sickle Cell Disease Status COMPLETED Phase NA
NCT02061202 Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT02042222 Novel Dose Escalation to Predict Treatment With Hydroxyurea Status COMPLETED Phase EARLY_PHASE1
NCT02041299 Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Status TERMINATED Phase PHASE4
NCT02029742 Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT Status COMPLETED Phase NA
NCT02013375 SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD Status TERMINATED Phase PHASE2
NCT02012777 Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease Status TERMINATED Phase PHASE1
NCT01987908 Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT01966731 Realizing Effectiveness Across Continents With Hydroxyurea (REACH) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01966367 CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01959958 Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease Status COMPLETED Phase N/A
NCT01954927 Pain Management in Children and Young Adults With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT01945073 Improving Disease Knowledge in Adolescents With Sickle Cell Disease Status COMPLETED Phase NA
NCT01940718 Androgen Regulation of Priapism in Sickle Cell Disease Status WITHDRAWN Phase EARLY_PHASE1